Elysium Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.elysiumrx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
Phase 1
Recruiting
- Conditions
- Acute Pain
- Interventions
- Drug: ETR028, ETR029, [ETR028 + ETR029] or HCBT
- First Posted Date
- 2022-10-07
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Elysium Therapeutics, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT05572190
- Locations
- 🇺🇸
Medpace, Cincinnati, Ohio, United States
News
No news found